Abstract
Background
The Endovascular Acute Stroke Intervention (EASI) trial was conceived as a pragmatic care trial, designed to integrate trial methods with clinical practice. Reporting the EASI experience was met with objections and criticisms during peer review concerning both scientific and ethical issues. Our goal is to discuss these criticisms in order to promote the pragmatic approach of care trials in outcome-based medical care.
Methods
The comments and criticisms of 11 reviewers from 5 journals were collected and analyzed. The EASI protocol was also compared to the protocols of seven thrombectomy trials using the pragmatic-explanatory continuum indicator summary (PRECIS).
Results
Main criticisms of EASI concerned selection criteria that were judged to be too vague and too inclusive, brain and vascular imaging methods that were not sufficiently prescribed by protocol, lack of blinding of outcome assessment, and lack of power. EASI was at the pragmatic end of the spectrum of thrombectomy trials.
Conclusion
The pragmatic care trial methodology is not currently well-established. More work needs to be done to integrate scientific methods and ethical care in the best medical interest of current patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Department of Radiology, Service of Neuroradiology, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357); Rothschild Foundation Hospital, Department of Interventional Neuroradiology, Paris, France (GRID:grid.419339.5)
2 Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Department of Radiology, Service of Neuroradiology, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357)
3 University of Montreal, Neurovascular Team, Division of Neurology, Department of Medicine, Centre hospitalier de l’Université de Montréal (CHUM), Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357)
4 University of Alberta hospital, Mackenzie Health Sciences Center, Department of Surgery, Division of Neurosurgery, Edmonton, Canada (GRID:grid.241114.3) (ISNI:0000 0004 0459 7625)
5 Boston Medical Center, Department of Neurology, Neurosurgery, and Radiology, Boston, USA (GRID:grid.239424.a) (ISNI:0000 0001 2183 6745)




